Sarantis Worldwide


Visit our group site

Sarantis Group| English

Or choose a location

INVESTOR'S PRESS

IR Releases

20 FEBRUARY 2025

Strong Presence of Sarantis Health & Care Division at the 16th Health Expo with clinéa, Lanes, PiC & Bio-Oil

Sarantis Health & Care Division successfully participated in the 16th Health Expo, one of Greece’s leading exhibitions in the Health and Care sector. The event, held on February 15-16 at the Megaron Athens International Conference Centre, brought together professionals and industry leaders, reaffirming the dynamic growth and significance of the health and care sector in Greece and beyond.

19 FEBRUARY 2025

Release Date of FY 2024 Annual Financial Results and Annual Financial Report & Conference Call Invitation

Sarantis Group will release its FY 2024 Annual Financial Results and Annual Financial Report, as follows: Wednesday, March 12th 2025 following Athens Exchange Market closing – Results and Report Release, which will be available at the Athens Stock Exchange website (www.

10 FEBRUARY 2025

Tesori d'Oriente Express | A Multi-Sensory Experience in Collaboration with Allbright Advertising, Honored with Major Distinctions at the 2025 Event Awards!

Sarantis Group and the Tesori d’Oriente team, in collaboration with Allbright Advertising, created the exciting event “Tesori d’Oriente Express” — a groundbreaking experience that captivated guests and earned significant accolades at the 2025 Event Awards.

10 FEBRUARY 2025

Announcement of Regulated Information : Transactions Notification

The company GR. SARANTIS S.A. announces, according to L.3556/2007 and the provisions of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, that Mr. Kyriakos Sarantis, Chairman of the Board of Directors and Executive Member of the Board, proceeded on February 5th of 2025 with the purchase of 30,112 common shares in total at the average price of 11.

10 FEBRUARY 2025

Release of Transactions Notification

The company GR. SARANTIS S.A. announces that Mrs. Aikaterini Saranti proceeded on February 7th of 2025 with the purchase of 2,964 common shares in total at the average price of 11.31 euro per share. This announcement is issued with a purpose of providing investors with comprehensive information, without being required by the regulatory framework, as Mrs.

6 FEBRUARY 2025

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on February 5th 2025 with the purchase of 4,714 own shares at the average price of 11.

5 FEBRUARY 2025

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on February 4th 2025 with the purchase of 2,119 own shares at the average price of 11.

4 FEBRUARY 2025

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on February 3rd 2025 with the purchase of 2,000 own shares at the average price of 11.

Press Releases

Want to learn more about the Group?
Explore our latest news regarding our brands, our activities, our people and our sustainability actions!

More
Change cookies consent Revoke cookies consent